Status:
COMPLETED
Treating Avoidant/Restrictive Food Intake Disorder (ARFID) Using Family-Based Treatment
Lead Sponsor:
Stanford University
Conditions:
Avoidant / Restrictive Food Intake Disorder
Eligibility:
All Genders
5-12 years
Phase:
NA
Brief Summary
Although Avoidant/Restrictive Food Intake Disorder (ARFID) was formally introduced in DSM-5, no specialized intervention has yet been empirically studied. This randomized controlled crossover trial (R...
Detailed Description
Potential subjects aged 5 years to 12 years, 11 months old with anorexia nervosa (AN) diagnosed with ARFID and their families will be recruited will be recruited through Stanford University, pediatric...
Eligibility Criteria
Inclusion
- children meeting DSM-V criteria for ARFID
- children between the ages of 5 to 12 years old
Exclusion
- any medical complications or severe mental disorder (psychosis, low-functioning Autism) that may reduce compliance with the study procedures or require more intensive care to manage the symptoms
- a severe parental mental disorder (e.g., psychotic depression, psychosis, substance dependence)
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03778216
Start Date
January 1 2017
End Date
March 7 2019
Last Update
March 17 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.